BioNTech SE (BNTX)

Basic

  • Market Cap

    $24.59B

  • EV

    $8,131.37M

  • Shares Out

    237.72M

  • Revenue

    €6,618.3M

  • Employees

    5,700

Margins

  • Gross

    90.87%

  • EBITDA

    62.08%

  • Operating

    60.95%

  • Pre-Tax

    55.84%

  • Net

    41.57%

  • FCF

    76.25%

Returns (5Yr Avg)

  • ROA

    20.84%

  • ROE

    24.97%

  • ROCE

    41.95%

  • ROIC

    28.09%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $123.95

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    €27.35

  • Earnings (Dil)

    €11.37

  • FCF

    €20.86

  • Book Value

    €83.57

Growth (CAGR)

  • Rev 3Yr

    242.39%

  • Rev 5Yr

    208.85%

  • Rev 10Yr

    —

  • Dil EPS 3Yr

    86.05%

  • Dil EPS 5Yr

    136.21%

  • Dil EPS 10Yr

    —

  • Rev Fwd 2Yr

    -51.9%

  • EBITDA Fwd 2Yr

    -80.08%

  • EPS Fwd 2Yr

    -74.39%

  • EPS LT Growth Est

    -56.19%

Dividends

  • Yield

    —

  • Payout

    —

  • DPS

    —

  • DPS Growth 3Yr

    —

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    —

Select a metric from the list below to chart it

Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM
Metric
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Total Revenues

127.6

108.6

482.3

18,976.7

17,310.6

6,618.3

Total Revenues % Chg.

107.1%

-14.9%

344.1%

3,834.6%

-8.8%

-64.4%

Cost of Goods Sold, Total

13.7

17.4

59.3

2,911.5

2,995.0

604.2

Gross Profit

113.9

91.2

423.0

16,065.2

14,315.6

6,014.1

Selling General & Admin Expenses, Total

32.3

48.7

108.5

336.2

544.2

568.8

R&D Expenses

140.6

226.5

645.0

949.2

1,537.0

1,715.1

Other Operating Expenses

-5.1

-2.5

-9.1

81.7

319.1

-303.4

Other Operating Expenses, Total

167.8

272.7

744.4

1,367.1

2,400.3

1,980.5

Operating Income

-53.9

-181.5

-321.4

14,698.1

11,915.3

4,033.6

Interest Expense, Total

-1.7

-1.7

-2.0

-5.4

-16.2

-3.9

Interest And Investment Income

2.0

1.8

1.6

1.5

48.5

276.0

Net Interest Expenses

0.3

0.1

-0.4

-3.9

32.3

272.1

Income (Loss) On Equity Invest.

-0.1

—

—

—

—

—

Currency Exchange Gains (Loss)

6.1

2.3

-42.6

512.5

792.4

-727.7

Other Non Operating Income (Expenses)

-0.0

-0.3

-20.4

-299.7

214.1

117.5

EBT, Excl. Unusual Items

-47.7

-179.4

-384.8

14,907.0

12,954.1

3,695.5

Other Unusual Items

0.1

—

239.0

139.4

—

—

EBT, Incl. Unusual Items

-47.7

-179.4

-145.8

15,046.4

12,954.1

3,695.5

Income Tax Expense

0.6

-0.2

-161.0

4,753.9

3,519.7

944.4

Earnings From Continuing Operations

-48.3

-179.2

15.2

10,292.5

9,434.4

2,751.1

Minority Interest

0.2

0.1

—

—

—

—

Net Income

-48.0

-179.1

15.2

10,292.5

9,434.4

2,751.1

Net Income to Common Incl Extra Items

-48.0

-179.1

15.2

10,292.5

9,434.4

2,751.1

Net Income to Common Excl. Extra Items

-48.0

-179.1

15.2

10,292.5

9,434.4

2,751.1

Total Shares Outstanding

190.7

226.8

241.5

242.5

243.2

237.7

Weighted Avg. Shares Outstanding

190.7

211.5

235.4

244.0

243.3

242.0

Weighted Avg. Shares Outstanding Dil

190.7

211.5

248.5

259.7

249.8

242.0

EPS

-0.3

-0.8

0.1

42.2

38.8

11.4

EPS Diluted

-0.3

-0.9

0.1

39.6

37.8

11.4

EBITDA

-34.8

-152.3

-289.0

14,744.3

11,979.8

4,108.4